目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Cell-based Assays Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Cell-based Assays Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Cell-based Assays Market: Products & Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Cell-based Assays Market: Products & Services Movement Analysis, 2023 & 2030 (USD Million)
4.3. Reagents
4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Assay Kits
4.4.1. Assay Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Cell Growth Assays
4.4.2.1. Cell Growth Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Reporter Gene Assays
4.4.3.1. Reporter Gene Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Cell Death Assays
4.4.4.1. Cell Death Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Second Messenger Assays
4.4.5.1. Second Messenger Assays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Microplates
4.5.1. Microplates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Probes & Labels
4.6.1. Probes & Labels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Instruments & Software
4.7.1. Instruments & Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Cell Lines
4.8.1. Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.2. Primary Cell Lines
4.8.2.1. Primary Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.3. Stem Cell Lines
4.8.3.1. Stem Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8.4. Immortalized Cell Lines
4.8.4.1. Immortalized Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cell-based Assays Market: Application & Trend Analysis
5.1. Segment Dashboard
5.2. Cell-based Assays Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. Basic Research
5.3.1. Basic Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Drug Discovery
5.4.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Other Applications
5.5.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cell-based Assays Market: End use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Cell-based Assays Market: End-user Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Pharmaceutical & Biotechnology Companies
6.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Academic & Research Institutes
6.4.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Contract Research Organizations (CROs)
6.5.1. Contract Research Organizations (CROs)Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Cell-based Assays Market: Regional Estimates & Trend Analysis
7.1. Cell-based Assays Market Share, By Region, 2023 & 2030 (USD Billion)
7.2. U.S.
7.2.1. U.S. Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.2. U.S.
7.2.2.1. U.S. Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.3. Canada
7.2.3.1. Canada Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.2.4. Mexico
7.2.4.1. Mexico Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3. Europe
7.3.1. Europe Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.2. UK
7.3.2.1. UK Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.3. Germany
7.3.3.1. Germany Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.4. France
7.3.4.1. France Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.5. Italy
7.3.5.1. Italy Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.6. Spain
7.3.6.1. Spain Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.7. Denmark
7.3.7.1. Denmark Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.8. Sweden
7.3.8.1. Sweden Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.3.9. Norway
7.3.9.1. Norway Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.2. Japan
7.4.2.1. Japan Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.3. China
7.4.3.1. China Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.4. India
7.4.4.1. India Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.5. Australia
7.4.5.1. Australia Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.6. South Korea
7.4.6.1. South Korea Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4.7. Thailand
7.4.7.1. Thailand Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Latin America
7.5.1. Latin America Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5.2. Brazil
7.5.2.1. Brazil Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5.3. Argentina
7.5.3.1. Argentina Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.2. South Africa
7.6.2.1. South Africa Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.4. UAE
7.6.4.1. UAE Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.6.5. Kuwait
7.6.5.1. Kuwait Cell-based Assays Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Bio-Rad Laboratories, Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/Strategic Initiatives
8.4.2. Corning Incorporated
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/Strategic Initiatives
8.4.3. Merck KGaA
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/Strategic Initiatives
8.4.4. Lonza Group AG
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/Strategic Initiatives
8.4.5. Charles River Laboratories
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/Strategic Initiatives
8.4.6. Becton, Dickinson and Company (BD)
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/Strategic Initiatives
8.4.7. Danaher Corporation
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/Strategic Initiatives
8.4.8. Promega Corporation
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/Strategic Initiatives
8.4.9. Thermo Fisher Scientific Inc.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/Strategic Initiatives
8.4.10. F. Hoffmann-La Roche Ltd. (Roche Holdings AG)
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/Strategic Initiatives
8.4.11. Perkin Elmer Inc.
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/Strategic Initiatives